NervGen Pharma Corp. NGENF
NGENF
NervGen Pharma Corp. JWCTF
JW (Cayman) Therapeutics Co. Ltd BRIBF
Brii Biosciences Limited GNFTF
Genfit S.A. SCNLF
Scancell Holdings plc MLLCF
Molecular Partners AG NDTP
NDT Pharmaceuticals Inc. BXPHF
Botanix Pharmaceuticals Limited IPHYF
Innate Pharma S.A. SPHDF
Santhera Pharmaceuticals Holding AG
NervGen Pharma Corp. JWCTF
JW (Cayman) Therapeutics Co. Ltd BRIBF
Brii Biosciences Limited GNFTF
Genfit S.A. SCNLF
Scancell Holdings plc MLLCF
Molecular Partners AG NDTP
NDT Pharmaceuticals Inc. BXPHF
Botanix Pharmaceuticals Limited IPHYF
Innate Pharma S.A. SPHDF
Santhera Pharmaceuticals Holding AG
Performance
| Periode | NGENF | JWCTF | BRIBF | GNFTF | SCNLF | MLLCF | NDTP | BXPHF | IPHYF | SPHDF |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 95.57 % | 44.00 % | -7.46 % | 16.95 % | 21.01 % | -17.06 % | 1 266.91 % | -72.81 % | 10.51 % | -9.49 % |
| YTD | 128.45 % | 122.22 % | 91.79 % | 16.95 % | -20.00 % | -14.84 % | 3 484.91 % | -75.36 % | -25.69 % | 41.72 % |
| 1Y | 143.12 % | 123.05 % | 91.79 % | 20.35 % | -20.00 % | -14.84 % | 3 484.91 % | -75.36 % | -25.69 % | 41.72 % |
| 3Y | 324.00 % | -29.36 % | -74.67 % | 24.32 % | -10.00 % | -41.28 % | 1 800.00 % | 215.40 % | -31.15 % | -99.05 % |
| 5Y | 217.37 % | -87.37 % | -91.25 % | -12.84 % | 79.33 % | -85.42 % | -47.22 % | -28.32 % | -49.88 % | 41 076 823.08 % |
| 10Y | 307.47 % | -87.37 % | -91.25 % | -88.00 % | -40.74 % | -84.53 % | 1 800.00 % | -60.58 % | -84.85 % | 1 530 963 302 652.29 % |
| From the beginning | 307.47 % | -87.37 % | -91.25 % | -85.60 % | -68.00 % | -84.53 % | -99.63 % | -60.58 % | -86.12 % | 29 666 666 566.67 % |